CARLOS MANUEL
PANIZO SANTOS
![Foto de CARLOS MANUEL](/img/nophoto.png)
![Foto de University of Tasmania](/img/noimage_org.png)
University of Tasmania
Hobart, AustraliaPublications in collaboration with researchers from University of Tasmania (1)
2023
-
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
Blood Advances, Vol. 7, Núm. 17, pp. 4926-4935